Navigation Links
Comparators in Medical News

Lilly to Unveil More Than 30 Studies at Premier Lung Cancer Meeting

...patients with nonsquamous non-small cell lung cancer (NSCLC) histology: An analysis of three large, randomized, phase III trials (* vs. the respective comparators in these three trials) D2.6: Oral Presentation: Aug. 4, 2009, 1:30 p.m. PDT Final results of a randomized phase II trial...

Non-Hormonal Therapies Aid Breast Cancer Patients

...ensus regarding the best dosage, timing, sequence or combination of therapies for treatment of metastatic breast cancer, due to the fact that standard comparators haven't been available, Dr. Philippe Bedard and Dr. Martine Piccart-Gebhart, of the Jules Bordet Institute in Brussels, Belgium, wrote in an accompany...

GSK Revises US Labeling for Avandia(R)

...ludes data from ADOPT and RECORD plus a third long-term trial in pre-diabetic patients (DREAM) which show there was no increased risk of Avandia over comparators with regard to myocardial infarction, mortality, or other non-heart failure cardiovascular events. GSK believes data from ongoing and future clinical...

GlaxoSmithKline Responds to JAMA Articles

...Actos meta-analysis shows no statistical difference between Avandia and comparators (a hazard ratio of 1.03). In RECORD, a study specifically designed to ... cardiovascular events, no real difference was seen between Avandia and comparators (HR 0.96). In all of these analyses, the Avandia and the Actos hazard r...
Comparators in Medical Technology

New Data Show In Vitro Potency of Doripenem Against Resistant Bacteria

...extended-spectrum Beta-lactamase producing Enterobacteriaceae (ESBLE) and ciprofloxacin-resistant Enterobacteriaceae (CIPRE) to doripenem and relevant comparators was evaluated. The data analyzed was pooled from six large, multi-national Phase III clinical trials, including trials that focused on complicated uri...

FDA Updates Label for AVANDIA(R) to Include Clinical Findings Demonstrating Sustained Glycemic Control for Up to Five Years

...ontrol at five years was 34 percent with glyburide, 21 percent with metformin and only 15 percent with AVANDIA. The difference between AVANDIA and the comparators was statistically significant. "GSK is pleased that the FDA has approved inclusion of the results from ADOPT, an important clinical trial that provi...

Vanda Presents Phase III Iloperidone Efficacy Data

.../day to 20-24 mg/day; similar reductions in BPRS scores were observed at six weeks for iloperidone in doses of 20-24 mg/day, as compared to the active comparators risperidone and haloperidol. The analysis further demonstrated that iloperidone had a favorable safety profile, most notably with regard to extrapyram...

Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria

...Staphylococcus aureus In Vitro," researchers detailed the antibacterial efficacy of physiologically attainable concentrations of oritavancin and other comparators tested against in vitro models of slow-growing and biofilm S. aureus. Slow-growing bacteria and biofilms are notoriously tolerant to antibiotics. In t...

July Issue of Journal of Antimicrobial Chemotherapy Highlights Study of Factive Tablets for Five-Day Treatment of Community-Acquired Pneumonia

...aximum-labeled duration of 7 days. In clinical trials, the discontinuation rate due to drug-related adverse events was similar for FACTIVE tablets and comparators (2.2% versus 2.1%, respectively). FACTIVE is contraindicated in patients with a history of hypersensitivity to gemifloxacin, fluoroquinolone antibio...
Comparators in Biological News

Prednisone tablets less variable than marketed drugs

...ts, said William Koch, Ph.D, chief reference materials officer for USP. USP Prednisone yielded an average variability of less than five percent, while comparators averaged about 13 percent. Established metrological principles were followed to ensure the tests objectivity, and it is clear that USP Prednisone Refe...
Comparators in Biological Technology

Shire plc: IFRS Results for the Year Ending December 31, 2007

...itory License Agreement was determined to be at current market rates. The valuation of the New River Collaboration Agreements and their current market comparators has been based upon information available at the time of the acquisition and using the expectations and assumptions that have been deemed reasonable b...

GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes

...ause, showed no statistically significant difference between rosiglitazone in combination with either metformin or sulfonylurea vs. the active comparators of metformin plus sulfonylurea. In addition, the RESULT clinical study specifically examined an elderly diabetic population, ages 59 to 89, in which ...

IFRS Information - First Half of 2007

...itory License Agreement was determined to be at current market rates. The valuation of the New River Collaboration Agreements and their current market comparators has been based upon information available at the time of the acquisition and using the expectations and assumptions that have been deemed reasonable b...

New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA

...cin had a faster time to cure (63% of patients successfully treated with daptomycin achieved a clinical cure within four to seven days versus 33% with comparators such as vancomyin and anti-staphylococcal penicillins).(6) Pivotal trial data published in The New England Journal of Medicine supports the use of da...
Other Tags
(Date:5/30/2015)... Alexandria, VA (PRWEB) May 30, 2015 ... Research Foundation interviewed Dr. Charles Simone and Dr. ... Medicine, during its ‘Meet the Mesothelioma Experts’ series. ... interviews focusing on mesothelioma centers of excellence. Drs. ... Foundation’s executive director, Mary Hesdorffer, with whom they ...
(Date:5/30/2015)... May 30, 2015 Responding to surging ... travelers who experienced OGAWA products while abroad, OGAWA-engineered massage ... , A leader in the Asian health and ... designer, researcher, developer and manufacturer of health and wellness ... craftsmanship of their products, health enthusiasts in Asia and ...
(Date:5/30/2015)... Cyclist Barry Haarde will commence ... World 2015: Piles of Miles” near San Francisco, ... hemophilia and encourage individuals to support needy hemophilic ... One Life supports nearly 1,200 impoverished children and ... direct sponsorships, scholarships and micro-enterprise grants. Hemophilia is ...
(Date:5/30/2015)... The iconic American actor, and host of “In ... segment on Medical Malpractice. This segment of “In America” ... health care field. , According to the Bureau of ... were filed, roughly only 20% of them made it ... while the remaining 30% were tossed out. (Source: ...
(Date:5/30/2015)... Venus Viva has proven to work ... deep wrinkles, stretch marks, pigmentation irregularities, and uneven texture ... Dr. F. Victor Rueckl of Lakes Dermatology in Las ... Las Vegas. This body image solution combines NanoFractional Radio ... delivers proven results through a skin heating process that ...
Breaking Medicine News(10 mins):Health News:Interview with Mesothelioma Experts, Drs. Simone and Alley Now Available on Demand 2Health News:Award-winning OGAWA Massage Chairs Finally Available for purchase in North America. 2Health News:Award-winning OGAWA Massage Chairs Finally Available for purchase in North America. 3Health News:Barry Haarde Cycles 4,000 Miles Across the USA for Hemophilia 2Health News:Announcing Ground-Breaking Technology for Anti-Aging, FDA Approved, Venus Viva. 2Health News:Announcing Ground-Breaking Technology for Anti-Aging, FDA Approved, Venus Viva. 3
(Date:5/11/2015)... , May 11, 2015  Through a well-rounded UAS ... had a strong showing at AUVSI,s Unmanned 2015 ... representatives of Ohio,s UAS industry met ... abroad from all points along the UAS ecosystem. ... Coalition,s (DDC) Vice President for Aerospace Rich Knoll . ...
(Date:5/6/2015)... , May 6, 2015 LifeBEAM, a developer ... helmet producer, announced today that they will expand their ... world,s first bio-sensing cycling helmet and the first joint ... two new colors in order to give cyclists more ... In addition, LifeBEAM and Lazer announced their plan to ...
(Date:4/21/2015)... April 21, 2015 High ... policies are boosting access control systems market in ... to a recently published report by TechSci Research " ... the access control systems market in Saudi ... by 2020.The access control systems market in the Kingdom ...
Breaking Biology News(10 mins):Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3
Other Contents